
IBD doc & Assistant Prof @TJUHospital | Passionate about #IBD & #weightwellness | IBD @PennGIHep | GI and MS @Columbiamed | IM & Med @DOMSinaiNYC
Philadelphia, PA
Joined March 2012
- Tweets241
- Following707
- Followers541
- Likes1.6K
Priya Sehgal MD MS MPH retweeted
🔥 HOT FROM ACG 2026 | NASHVILLE
Five IBD Studies Worth a Closer Look!
Another exciting ACG meeting, another opportunity to reflect on where IBD care is heading.
From innovative drug delivery strategies to better symptom control, complex patient populations, and reproductive health, the science continues to evolve.
For this special edition of IBD Library™, we invited Dr. @AsadurRahman87 , Medical Director of the IBD Center and Associate Program Director of the GI Fellowship at Cleveland Clinic Florida, to review five interesting studies presented at ACG 2026.
🔬 What's inside?
💉 Subcutaneous vs IV infliximab: Could route of administration influence outcomes in ileal Crohn's disease?
💊 Risankizumab AFFIRM trial: Another step toward an entirely subcutaneous treatment strategy.
🌙 Obefazimod in UC: Because bowel urgency and uninterrupted sleep matter to our patients.
🩺 JAK inhibitors in PSC associated IBD: Exploring options for a particularly challenging population.
👶 Fertility and IBD: Encouraging insights from the WIsDoM cohort on assisted reproductive technology.
Innovation in IBD is no longer just about introducing another effective molecule. It is also about how we deliver treatment, what outcomes we prioritize, and how we address the needs of patients often underrepresented in clinical trials.
Of course, conference abstracts generate important questions, but not necessarily immediate changes in practice.
A special thank you to Dr. Asad ur Rahman for contributing his expertise to this edition of IBD Library™.
📖 Enjoy the review, and let us know:
Which of these five studies caught your attention the most?
#IBDLibrary #ACG2026 #CrohnsDisease #UlcerativeColitis #IBD #Gastroenterology #ClinicalResearch #MedicalEducation
🤖 Made with AI
Priya Sehgal MD MS MPH retweeted
1/3:
What #IBD meds work in ileal vs colonic CD? @AGA_CGH @AmerGastroAssn
✅Works in ileaIl: IL-23s and VDZ (!)
🟠Doesn’t work: JAKi (!)
Caveats - but damn clever study.
Rare 3 part post - look at all post for a simple methods (👇🏾) or skip to #3/3
cghjournal.org/article/S1542…
Priya Sehgal MD MS MPH retweeted
Los agonistas del receptor de GLP-1 no solo bajan glucosa y peso, cada vez hay más evidencia de un efecto antiinflamatorio directo en múltiples órganos.
La inflamación crónica es el hilo que conecta diabetes, enfermedad cardiovascular, hígado y cerebro.
Revisión de esta semana en JCEM
👇 🔗 pubmed.ncbi.nlm.nih.gov/4221…
Priya Sehgal MD MS MPH retweeted
Protocol for the ongoing consensus work on this topic in IBD with my co-PIs @amjohnsonMD @AndresYarur and a super team including @jalpa_devi @SamiSamaanMD @phillyIBDdoc Matt Vincent Shannon Coombs @MouhandMD and RAND/UCLA methodologist @EdBarnesMD
Stay tuned for the actual 3 part survey output:
Modulate Obesity and relateD metabolic complIcations For Yielding improvements in IBD outcomes (MODIFY-IBD): consensus on obesity and cardiometabolic comorbidities in inflammatory bowel disease using systematic reviews and the RAND/UCLA appropriateness m… @BMJ_Open bmjopen.bmj.com/content/16/5…
Priya Sehgal MD MS MPH retweeted
⏳Our global patient survey on #Obesity, metabolic health, & #IBD is still OPEN.
@UNMC_GIHEP @MayoClinic @washumedicine @CedarsSinai @ibdesis @saia_gi @P_DeepakIBDMD @ownyourcrohns @CrohnsColitisFn @AmerGastroAssn @AndresYarur @amjohnsonMD
Survey link: tinyurl.com/37pufehu
Wash U in collaboration with UNMC, Mayo Clinic, Cedars Sinai and SAIA / IBDesis is conducting a survey to better understand patient experiences with weight management and metabolic health in IBD.
Please take the following survey: wustl.az1.qualtrics.com/jfe/…. This survey is available across the globe for our patients who would like to have a voice on the topic!
And always know that your lived experiences will guide future research, education, and discussion on the cutting-edge topic of #obesity & #IBD.
If interested in participating in a PPI Day to further this research, please email @jalpa_devi and join us on Friday, June 5th from 11am to 1pm CDT. Thank you very much!
#SAIA #IBDesis #CultureAndGI
Priya Sehgal MD MS MPH retweeted
Author @FrankIScottMD provides a great breakdown of our new living on managing moderate-to-severe Crohn’s disease. Clear, actionable insights for clinicians and patients alike. Looking forward to the full thread of recommendations. 👇
🚨AGA New Guideline Alert🚨
🔗gastro.org/clinical-guidance…
▶️AGA Living Guideline: Pharmacologic Management of Moderate-to-Severe Crohn’s Disease
I’ll break down its 16 recommendations down over the next 10 tweets 🧵 👇
#AGA #GI #CD #IBD #MedTwitter
1/10
Priya Sehgal MD MS MPH retweeted
New Name, Growing Mission AND…🥁
Revamped Website & Socials 🙌🏽
Check out Strategic Alliance for Intercultural Advocacy in GI’s new website: saia-gi.org
We are thrilled to share our website & social media reflect SAIA’s expanded focus to Culture & GI!
Priya Sehgal MD MS MPH retweeted
SAIA is proud to partner with Advances in Inflammatory Bowel Diseases (@ibdconference) 2025!
Join us at the Walt Disney World Swan and Dolphin Resort in Orlando from Dec 8–10, 2025, for cutting-edge education, expert-led sessions & networking opportunities, with pre-conference workshops starting December 6-7.
Register here: hmpglobalevents.com/aibd/rat…
You can save $100 on registration with code 'SAIA' at checkout. Don’t miss this opportunity to be part of the year’s most impactful IBD conference 💥
Priya Sehgal MD MS MPH retweeted
This festive season, we’ve partnered with Crohn’s & Colitis Foundation on a FAB talk!
Join Leana Patel moderating @ownyourcrohns, @phillyIBDdoc & @LivingWithUmeed as they discuss how to celebrate cultural festivals like Diwali with IBD!
Tune in on Oct 9th on IG on saia_ibd / crohnscolitisfoundation!
Priya Sehgal MD MS MPH retweeted
Lovely first session! “Everything You Need to Know” high yield sessions from our experts #psg #Gastroenterology
Priya Sehgal MD MS MPH retweeted
Wowza! That was one of the highest yield talks I have ever heard on the Nether region on Proctitis, Pouchitis and Fissures ! Wonderful job by Dr Shivali Berera ! @penngihep @PaGastroSoc #PSG2025
Priya Sehgal MD MS MPH retweeted
'Free to read' via bit.ly/45GWWRG
"Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease"
by Mahadevan et al
#IBD #GItwitter #pregnancy
Priya Sehgal MD MS MPH retweeted
#CGH4ALL 📣
💊 GLP-1 agonists in IBD?
👀 Safe, effective for weight loss
🔥 May help reduce inflammation (↓ CRP)
🌟 Especially promising in ulcerative colitis!
Read the complete study here @AGA_CGH
🔗 doi.org/10.1016/j.cgh.2024.1…
Reported by @arianapg
@phillyIBDdoc @blakely_md @DrsMeena @JamesLewisGIEpi @FITWITMD @PennIBDDoc
@ManuelBragaMD @EdwardLoftus2 @UmaMahadevanIBD @SunandaKaneMD @MRegueiroMD @IBD_FloMD
Priya Sehgal MD MS MPH retweeted
True honor to be a part of this very detailed scoping review on 'Inflammatory bowel disease in south Asia @LancetGastroHep Tremendous work led @shabarishenoy @DrAnuraagJ #ManasiAgrawalMD @ibdseb @drvishal82 @ownyourcrohns @southasianIBD @ibdesis sciencedirect.com/science/ar…
Priya Sehgal MD MS MPH retweeted
Obesity is linked to worse outcomes in patients with #ulcerativecolitis:
✅ ⬆️ risk of steroid use
✅ ⬇️ efficacy of advanced therapies (tumour necrosis factor α inhibitors, vedolizumab, ustekinumab and Janus kinase inhibitors)
✅ ⬆️ risk of surgical removal of all the colon
@APandT
🎓 @phillyIBDdoc @akMD03 @JamesLewisGIEpi @PennIBDDoc @GKochharMD @FarrayeIBD
Priya Sehgal MD MS MPH retweeted
Patients with obesity and ulcerative colitis are at an increased risk of composite outcome of steroid use, change in advanced therapy and colectomy.
Read the paper by Desai et al at bit.ly/3EgU9mP
#obesity #ulcerativecolitis #IBD #GItwitter
Priya Sehgal MD MS MPH retweeted
EOSINOPHILS in IBD? Our work in #JCC suggests anti-IL-12/23 may be more effective in managing eosinophil-associated inflammation in IBD. Eosinophil reduction was identified as a marker of early response to ustekinumab in both UC/CD, but not adalimumab or vedolizumab. Link below
Priya Sehgal MD MS MPH retweeted
Pregnant women with IBD should start low dose aspirin between weeks 12-16 gestation. This data supports no increase in flares. Take with food! @PIANOIBD @MLongMD
Great work from @zmemel @PIANOIBD. The Effect of Low-dose Aspirin on Disease Activity in... : Official journal of the American College of Gastroenterology | ACG journals.lww.com/ajg/abstrac…
Priya Sehgal MD MS MPH retweeted
Hear directly from the experts at our next #GastroBites! The authors of the AGA's 1️⃣st living guideline for the management of moderate-to-severe #ulcerativecolitis will discuss best practices and recommendations. @EdwardLoftus2 @AshwinMDIBD
Register: ow.ly/5qsw50UulCx
Priya Sehgal MD MS MPH retweeted
#AIBD24 @IBDConference 🌟panel discussion
💎+ Quantiferon w nml CxRay:
✅Treat w Rifampin x 4 mos
✅OK to start #IBD advanced Rx after 2 wks of Rifampin
💎Think intestinal TB
✅Involve ileum, R colon
✅Ulcers are transverse & not linear like in Crohns
Incredibly high yield topic on everyday IBD in terms of things to monitor in patients with IBD! @DCharabaty @FarrayeIBD @PDulaiMD @IBDConference #AIBD2024






































